Shanghai RAAS announces progress on share repurchase program

Shanghai RAAS Blood Products Co., Ltd. (SZSE:002252) announced that it has made further progress in its share repurchase program. As of April 7, 2025, the company has cumulatively repurchased 15,649,851 shares, representing 0.24% of the company's total share capital, via a dedicated securities account through centralized bidding. The highest transaction price was CNY 7.09 per share, and the lowest was CNY 6.62 per share, with the total transaction amount reaching CNY 108,426,420.12 (excluding transaction commissions). The repurchased shares are intended for employee stock ownership plans or equity incentives, and the repurchase activities are in compliance with the company's repurchase plan and related regulations. The company intends to continue implementing the repurchase plan based on market conditions, while adhering to relevant laws and regulations.